0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Injectable Thyroid Drug Market Research Report 2024
Published Date: May 2024
|
Report Code: QYRE-Auto-7L17434
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Injectable Thyroid Drug Market Research Report 2024
BUY CHAPTERS

Global Injectable Thyroid Drug Market Research Report 2024

Code: QYRE-Auto-7L17434
Report
May 2024
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Injectable Thyroid Drug Market

Injectable thyroid drugs are medications administered via injection to treat thyroid disorders. These medications are typically reserved for situations where oral medications are not suitable or effective, such as in cases of severe thyroid dysfunction, malabsorption issues, or when a rapid response is needed.
The global Injectable Thyroid Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Injectable Thyroid Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Injectable Thyroid Drug is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Injectable Thyroid Drug include Genzyme Corporation (Sanofi), Fresenius Kabi, XGEN PHARMACEUTICALS DJB, Inc., Zydus Lifesciences, DMS Pharma, MAlA Pharmaceuticals, Inc., App Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Injectable Thyroid Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Thyroid Drug.
The Injectable Thyroid Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Injectable Thyroid Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Injectable Thyroid Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Injectable Thyroid Drug Market Report

Report Metric Details
Report Name Injectable Thyroid Drug Market
Segment by Type
  • Levothyroxine Sodium
  • Liothyronine Sodium
Segment by Application
  • Hospital
  • Clinic
  • Online Sales
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Genzyme Corporation (Sanofi), Fresenius Kabi, XGEN PHARMACEUTICALS DJB, Inc., Zydus Lifesciences, DMS Pharma, MAlA Pharmaceuticals, Inc., App Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Injectable Thyroid Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Injectable Thyroid Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Injectable Thyroid Drug Market report?

Ans: The main players in the Injectable Thyroid Drug Market are Genzyme Corporation (Sanofi), Fresenius Kabi, XGEN PHARMACEUTICALS DJB, Inc., Zydus Lifesciences, DMS Pharma, MAlA Pharmaceuticals, Inc., App Pharmaceuticals

What are the Application segmentation covered in the Injectable Thyroid Drug Market report?

Ans: The Applications covered in the Injectable Thyroid Drug Market report are Hospital, Clinic, Online Sales, Other

What are the Type segmentation covered in the Injectable Thyroid Drug Market report?

Ans: The Types covered in the Injectable Thyroid Drug Market report are Levothyroxine Sodium, Liothyronine Sodium

1 Injectable Thyroid Drug Market Overview
1.1 Product Definition
1.2 Injectable Thyroid Drug by Type
1.2.1 Global Injectable Thyroid Drug Market Value Comparison by Type (2024-2030)
1.2.2 Levothyroxine Sodium
1.2.3 Liothyronine Sodium
1.3 Injectable Thyroid Drug by Application
1.3.1 Global Injectable Thyroid Drug Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Online Sales
1.3.5 Other
1.4 Global Injectable Thyroid Drug Market Size Estimates and Forecasts
1.4.1 Global Injectable Thyroid Drug Revenue 2019-2030
1.4.2 Global Injectable Thyroid Drug Sales 2019-2030
1.4.3 Global Injectable Thyroid Drug Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Injectable Thyroid Drug Market Competition by Manufacturers
2.1 Global Injectable Thyroid Drug Sales Market Share by Manufacturers (2019-2024)
2.2 Global Injectable Thyroid Drug Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Injectable Thyroid Drug Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Injectable Thyroid Drug, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Injectable Thyroid Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Injectable Thyroid Drug, Product Type & Application
2.7 Global Key Manufacturers of Injectable Thyroid Drug, Date of Enter into This Industry
2.8 Global Injectable Thyroid Drug Market Competitive Situation and Trends
2.8.1 Global Injectable Thyroid Drug Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Injectable Thyroid Drug Players Market Share by Revenue
2.8.3 Global Injectable Thyroid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Injectable Thyroid Drug Market Scenario by Region
3.1 Global Injectable Thyroid Drug Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Injectable Thyroid Drug Sales by Region: 2019-2030
3.2.1 Global Injectable Thyroid Drug Sales by Region: 2019-2024
3.2.2 Global Injectable Thyroid Drug Sales by Region: 2025-2030
3.3 Global Injectable Thyroid Drug Revenue by Region: 2019-2030
3.3.1 Global Injectable Thyroid Drug Revenue by Region: 2019-2024
3.3.2 Global Injectable Thyroid Drug Revenue by Region: 2025-2030
3.4 North America Injectable Thyroid Drug Market Facts & Figures by Country
3.4.1 North America Injectable Thyroid Drug Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Injectable Thyroid Drug Sales by Country (2019-2030)
3.4.3 North America Injectable Thyroid Drug Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Injectable Thyroid Drug Market Facts & Figures by Country
3.5.1 Europe Injectable Thyroid Drug Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Injectable Thyroid Drug Sales by Country (2019-2030)
3.5.3 Europe Injectable Thyroid Drug Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Injectable Thyroid Drug Market Facts & Figures by Region
3.6.1 Asia Pacific Injectable Thyroid Drug Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Injectable Thyroid Drug Sales by Region (2019-2030)
3.6.3 Asia Pacific Injectable Thyroid Drug Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Injectable Thyroid Drug Market Facts & Figures by Country
3.7.1 Latin America Injectable Thyroid Drug Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Injectable Thyroid Drug Sales by Country (2019-2030)
3.7.3 Latin America Injectable Thyroid Drug Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Injectable Thyroid Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Injectable Thyroid Drug Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Injectable Thyroid Drug Sales by Country (2019-2030)
3.8.3 Middle East and Africa Injectable Thyroid Drug Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Injectable Thyroid Drug Sales by Type (2019-2030)
4.1.1 Global Injectable Thyroid Drug Sales by Type (2019-2024)
4.1.2 Global Injectable Thyroid Drug Sales by Type (2025-2030)
4.1.3 Global Injectable Thyroid Drug Sales Market Share by Type (2019-2030)
4.2 Global Injectable Thyroid Drug Revenue by Type (2019-2030)
4.2.1 Global Injectable Thyroid Drug Revenue by Type (2019-2024)
4.2.2 Global Injectable Thyroid Drug Revenue by Type (2025-2030)
4.2.3 Global Injectable Thyroid Drug Revenue Market Share by Type (2019-2030)
4.3 Global Injectable Thyroid Drug Price by Type (2019-2030)
5 Segment by Application
5.1 Global Injectable Thyroid Drug Sales by Application (2019-2030)
5.1.1 Global Injectable Thyroid Drug Sales by Application (2019-2024)
5.1.2 Global Injectable Thyroid Drug Sales by Application (2025-2030)
5.1.3 Global Injectable Thyroid Drug Sales Market Share by Application (2019-2030)
5.2 Global Injectable Thyroid Drug Revenue by Application (2019-2030)
5.2.1 Global Injectable Thyroid Drug Revenue by Application (2019-2024)
5.2.2 Global Injectable Thyroid Drug Revenue by Application (2025-2030)
5.2.3 Global Injectable Thyroid Drug Revenue Market Share by Application (2019-2030)
5.3 Global Injectable Thyroid Drug Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Genzyme Corporation (Sanofi)
6.1.1 Genzyme Corporation (Sanofi) Company Information
6.1.2 Genzyme Corporation (Sanofi) Description and Business Overview
6.1.3 Genzyme Corporation (Sanofi) Injectable Thyroid Drug Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Genzyme Corporation (Sanofi) Injectable Thyroid Drug Product Portfolio
6.1.5 Genzyme Corporation (Sanofi) Recent Developments/Updates
6.2 Fresenius Kabi
6.2.1 Fresenius Kabi Company Information
6.2.2 Fresenius Kabi Description and Business Overview
6.2.3 Fresenius Kabi Injectable Thyroid Drug Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Fresenius Kabi Injectable Thyroid Drug Product Portfolio
6.2.5 Fresenius Kabi Recent Developments/Updates
6.3 XGEN PHARMACEUTICALS DJB, Inc.
6.3.1 XGEN PHARMACEUTICALS DJB, Inc. Company Information
6.3.2 XGEN PHARMACEUTICALS DJB, Inc. Description and Business Overview
6.3.3 XGEN PHARMACEUTICALS DJB, Inc. Injectable Thyroid Drug Sales, Revenue and Gross Margin (2019-2024)
6.3.4 XGEN PHARMACEUTICALS DJB, Inc. Injectable Thyroid Drug Product Portfolio
6.3.5 XGEN PHARMACEUTICALS DJB, Inc. Recent Developments/Updates
6.4 Zydus Lifesciences
6.4.1 Zydus Lifesciences Company Information
6.4.2 Zydus Lifesciences Description and Business Overview
6.4.3 Zydus Lifesciences Injectable Thyroid Drug Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Zydus Lifesciences Injectable Thyroid Drug Product Portfolio
6.4.5 Zydus Lifesciences Recent Developments/Updates
6.5 DMS Pharma
6.5.1 DMS Pharma Company Information
6.5.2 DMS Pharma Description and Business Overview
6.5.3 DMS Pharma Injectable Thyroid Drug Sales, Revenue and Gross Margin (2019-2024)
6.5.4 DMS Pharma Injectable Thyroid Drug Product Portfolio
6.5.5 DMS Pharma Recent Developments/Updates
6.6 MAlA Pharmaceuticals, Inc.
6.6.1 MAlA Pharmaceuticals, Inc. Company Information
6.6.2 MAlA Pharmaceuticals, Inc. Description and Business Overview
6.6.3 MAlA Pharmaceuticals, Inc. Injectable Thyroid Drug Sales, Revenue and Gross Margin (2019-2024)
6.6.4 MAlA Pharmaceuticals, Inc. Injectable Thyroid Drug Product Portfolio
6.6.5 MAlA Pharmaceuticals, Inc. Recent Developments/Updates
6.7 App Pharmaceuticals
6.7.1 App Pharmaceuticals Company Information
6.7.2 App Pharmaceuticals Description and Business Overview
6.7.3 App Pharmaceuticals Injectable Thyroid Drug Sales, Revenue and Gross Margin (2019-2024)
6.7.4 App Pharmaceuticals Injectable Thyroid Drug Product Portfolio
6.7.5 App Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Injectable Thyroid Drug Industry Chain Analysis
7.2 Injectable Thyroid Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Injectable Thyroid Drug Production Mode & Process
7.4 Injectable Thyroid Drug Sales and Marketing
7.4.1 Injectable Thyroid Drug Sales Channels
7.4.2 Injectable Thyroid Drug Distributors
7.5 Injectable Thyroid Drug Customers
8 Injectable Thyroid Drug Market Dynamics
8.1 Injectable Thyroid Drug Industry Trends
8.2 Injectable Thyroid Drug Market Drivers
8.3 Injectable Thyroid Drug Market Challenges
8.4 Injectable Thyroid Drug Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Injectable Thyroid Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Injectable Thyroid Drug Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Injectable Thyroid Drug Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Injectable Thyroid Drug Sales (K Units) of Key Manufacturers (2019-2024)
 Table 5. Global Injectable Thyroid Drug Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Injectable Thyroid Drug Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Injectable Thyroid Drug Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Injectable Thyroid Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Injectable Thyroid Drug, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Injectable Thyroid Drug, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Injectable Thyroid Drug, Product Type & Application
 Table 12. Global Key Manufacturers of Injectable Thyroid Drug, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Injectable Thyroid Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Thyroid Drug as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Injectable Thyroid Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Injectable Thyroid Drug Sales by Region (2019-2024) & (K Units)
 Table 18. Global Injectable Thyroid Drug Sales Market Share by Region (2019-2024)
 Table 19. Global Injectable Thyroid Drug Sales by Region (2025-2030) & (K Units)
 Table 20. Global Injectable Thyroid Drug Sales Market Share by Region (2025-2030)
 Table 21. Global Injectable Thyroid Drug Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Injectable Thyroid Drug Revenue Market Share by Region (2019-2024)
 Table 23. Global Injectable Thyroid Drug Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Injectable Thyroid Drug Revenue Market Share by Region (2025-2030)
 Table 25. North America Injectable Thyroid Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Injectable Thyroid Drug Sales by Country (2019-2024) & (K Units)
 Table 27. North America Injectable Thyroid Drug Sales by Country (2025-2030) & (K Units)
 Table 28. North America Injectable Thyroid Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Injectable Thyroid Drug Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Injectable Thyroid Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Injectable Thyroid Drug Sales by Country (2019-2024) & (K Units)
 Table 32. Europe Injectable Thyroid Drug Sales by Country (2025-2030) & (K Units)
 Table 33. Europe Injectable Thyroid Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Injectable Thyroid Drug Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Injectable Thyroid Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Injectable Thyroid Drug Sales by Region (2019-2024) & (K Units)
 Table 37. Asia Pacific Injectable Thyroid Drug Sales by Region (2025-2030) & (K Units)
 Table 38. Asia Pacific Injectable Thyroid Drug Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Injectable Thyroid Drug Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Injectable Thyroid Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Injectable Thyroid Drug Sales by Country (2019-2024) & (K Units)
 Table 42. Latin America Injectable Thyroid Drug Sales by Country (2025-2030) & (K Units)
 Table 43. Latin America Injectable Thyroid Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Injectable Thyroid Drug Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Injectable Thyroid Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Injectable Thyroid Drug Sales by Country (2019-2024) & (K Units)
 Table 47. Middle East and Africa Injectable Thyroid Drug Sales by Country (2025-2030) & (K Units)
 Table 48. Middle East and Africa Injectable Thyroid Drug Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Injectable Thyroid Drug Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Injectable Thyroid Drug Sales (K Units) by Type (2019-2024)
 Table 51. Global Injectable Thyroid Drug Sales (K Units) by Type (2025-2030)
 Table 52. Global Injectable Thyroid Drug Sales Market Share by Type (2019-2024)
 Table 53. Global Injectable Thyroid Drug Sales Market Share by Type (2025-2030)
 Table 54. Global Injectable Thyroid Drug Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Injectable Thyroid Drug Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Injectable Thyroid Drug Revenue Market Share by Type (2019-2024)
 Table 57. Global Injectable Thyroid Drug Revenue Market Share by Type (2025-2030)
 Table 58. Global Injectable Thyroid Drug Price (US$/Unit) by Type (2019-2024)
 Table 59. Global Injectable Thyroid Drug Price (US$/Unit) by Type (2025-2030)
 Table 60. Global Injectable Thyroid Drug Sales (K Units) by Application (2019-2024)
 Table 61. Global Injectable Thyroid Drug Sales (K Units) by Application (2025-2030)
 Table 62. Global Injectable Thyroid Drug Sales Market Share by Application (2019-2024)
 Table 63. Global Injectable Thyroid Drug Sales Market Share by Application (2025-2030)
 Table 64. Global Injectable Thyroid Drug Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Injectable Thyroid Drug Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Injectable Thyroid Drug Revenue Market Share by Application (2019-2024)
 Table 67. Global Injectable Thyroid Drug Revenue Market Share by Application (2025-2030)
 Table 68. Global Injectable Thyroid Drug Price (US$/Unit) by Application (2019-2024)
 Table 69. Global Injectable Thyroid Drug Price (US$/Unit) by Application (2025-2030)
 Table 70. Genzyme Corporation (Sanofi) Company Information
 Table 71. Genzyme Corporation (Sanofi) Description and Business Overview
 Table 72. Genzyme Corporation (Sanofi) Injectable Thyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 73. Genzyme Corporation (Sanofi) Injectable Thyroid Drug Product
 Table 74. Genzyme Corporation (Sanofi) Recent Developments/Updates
 Table 75. Fresenius Kabi Company Information
 Table 76. Fresenius Kabi Description and Business Overview
 Table 77. Fresenius Kabi Injectable Thyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 78. Fresenius Kabi Injectable Thyroid Drug Product
 Table 79. Fresenius Kabi Recent Developments/Updates
 Table 80. XGEN PHARMACEUTICALS DJB, Inc. Company Information
 Table 81. XGEN PHARMACEUTICALS DJB, Inc. Description and Business Overview
 Table 82. XGEN PHARMACEUTICALS DJB, Inc. Injectable Thyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 83. XGEN PHARMACEUTICALS DJB, Inc. Injectable Thyroid Drug Product
 Table 84. XGEN PHARMACEUTICALS DJB, Inc. Recent Developments/Updates
 Table 85. Zydus Lifesciences Company Information
 Table 86. Zydus Lifesciences Description and Business Overview
 Table 87. Zydus Lifesciences Injectable Thyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 88. Zydus Lifesciences Injectable Thyroid Drug Product
 Table 89. Zydus Lifesciences Recent Developments/Updates
 Table 90. DMS Pharma Company Information
 Table 91. DMS Pharma Description and Business Overview
 Table 92. DMS Pharma Injectable Thyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 93. DMS Pharma Injectable Thyroid Drug Product
 Table 94. DMS Pharma Recent Developments/Updates
 Table 95. MAlA Pharmaceuticals, Inc. Company Information
 Table 96. MAlA Pharmaceuticals, Inc. Description and Business Overview
 Table 97. MAlA Pharmaceuticals, Inc. Injectable Thyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 98. MAlA Pharmaceuticals, Inc. Injectable Thyroid Drug Product
 Table 99. MAlA Pharmaceuticals, Inc. Recent Developments/Updates
 Table 100. App Pharmaceuticals Company Information
 Table 101. App Pharmaceuticals Description and Business Overview
 Table 102. App Pharmaceuticals Injectable Thyroid Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
 Table 103. App Pharmaceuticals Injectable Thyroid Drug Product
 Table 104. App Pharmaceuticals Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Injectable Thyroid Drug Distributors List
 Table 108. Injectable Thyroid Drug Customers List
 Table 109. Injectable Thyroid Drug Market Trends
 Table 110. Injectable Thyroid Drug Market Drivers
 Table 111. Injectable Thyroid Drug Market Challenges
 Table 112. Injectable Thyroid Drug Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Injectable Thyroid Drug
 Figure 2. Global Injectable Thyroid Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Injectable Thyroid Drug Market Share by Type: 2023 & 2030
 Figure 4. Levothyroxine Sodium Product Picture
 Figure 5. Liothyronine Sodium Product Picture
 Figure 6. Global Injectable Thyroid Drug Market Value by Application (2024-2030) & (US$ Million)
 Figure 7. Global Injectable Thyroid Drug Market Share by Application: 2023 & 2030
 Figure 8. Hospital
 Figure 9. Clinic
 Figure 10. Online Sales
 Figure 11. Other
 Figure 12. Global Injectable Thyroid Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Injectable Thyroid Drug Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Injectable Thyroid Drug Sales (2019-2030) & (K Units)
 Figure 15. Global Injectable Thyroid Drug Average Price (US$/Unit) & (2019-2030)
 Figure 16. Injectable Thyroid Drug Report Years Considered
 Figure 17. Injectable Thyroid Drug Sales Share by Manufacturers in 2023
 Figure 18. Global Injectable Thyroid Drug Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Injectable Thyroid Drug Players: Market Share by Revenue in Injectable Thyroid Drug in 2023
 Figure 20. Injectable Thyroid Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Injectable Thyroid Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Injectable Thyroid Drug Sales Market Share by Country (2019-2030)
 Figure 23. North America Injectable Thyroid Drug Revenue Market Share by Country (2019-2030)
 Figure 24. United States Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Injectable Thyroid Drug Sales Market Share by Country (2019-2030)
 Figure 27. Europe Injectable Thyroid Drug Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Injectable Thyroid Drug Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Injectable Thyroid Drug Revenue Market Share by Region (2019-2030)
 Figure 35. China Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Injectable Thyroid Drug Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Injectable Thyroid Drug Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Injectable Thyroid Drug Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Injectable Thyroid Drug Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Injectable Thyroid Drug by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Injectable Thyroid Drug by Type (2019-2030)
 Figure 54. Global Injectable Thyroid Drug Price (US$/Unit) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Injectable Thyroid Drug by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Injectable Thyroid Drug by Application (2019-2030)
 Figure 57. Global Injectable Thyroid Drug Price (US$/Unit) by Application (2019-2030)
 Figure 58. Injectable Thyroid Drug Value Chain
 Figure 59. Injectable Thyroid Drug Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS